Safety and Immunogenicity of a Booster Dose of -H5N1 Influenza Vaccine
Clinical trial NCT00561184 · COMPLETED
Trial details
- NCT number
- NCT00561184
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2007-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.